Theracryf (TCF) Competitors GBX 0.25 +0.02 (+6.38%) As of 08/1/2025 11:04 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock TCF vs. STL, HWC, AGM, FCRM, SFE, ABTX, PGY, STEL, TCA, and CHOCShould you be buying Theracryf stock or one of its competitors? The main competitors of Theracryf include Stilo International (STL), Highway Capital (HWC), Applied Graphene Materials (AGM), Fulcrum Utility Services (FCRM), Safestyle UK (SFE), ABTX.L (ABTX), Progility (PGY), Stellar Diamonds (STEL), Terra Capital (TCA), and United Cacao Limited SEZC (CHOC). These companies are all part of the "banking" industry. Theracryf vs. Its Competitors Stilo International Highway Capital Applied Graphene Materials Fulcrum Utility Services Safestyle UK ABTX.L Progility Stellar Diamonds Terra Capital United Cacao Limited SEZC Stilo International (LON:STL) and Theracryf (LON:TCF) are both small-cap banking companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, valuation and dividends. Which has higher valuation and earnings, STL or TCF? Stilo International has higher revenue and earnings than Theracryf. Theracryf is trading at a lower price-to-earnings ratio than Stilo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStilo International£1.42M0.00N/A£0.10N/ATheracryf£687.67K1.74-£5.45M-£1.03-0.24 Is STL or TCF more profitable? Stilo International has a net margin of 0.00% compared to Theracryf's net margin of -792.17%. Stilo International's return on equity of 0.00% beat Theracryf's return on equity.Company Net Margins Return on Equity Return on Assets Stilo InternationalN/A N/A N/A Theracryf -792.17%-99.97%-48.26% Does the media prefer STL or TCF? In the previous week, Stilo International's average media sentiment score of 0.00 equaled Theracryf'saverage media sentiment score. Company Overall Sentiment Stilo International Neutral Theracryf Neutral Do insiders & institutionals hold more shares of STL or TCF? 37.0% of Theracryf shares are owned by institutional investors. 42.9% of Theracryf shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryStilo International beats Theracryf on 6 of the 8 factors compared between the two stocks. Get Theracryf News Delivered to You Automatically Sign up to receive the latest news and ratings for TCF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TCF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart TCF vs. The Competition Export to ExcelMetricTheracryfBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.19M£134.47M£5.48B£3.03BDividend YieldN/A3.74%4.73%5.02%P/E Ratio-0.243.7828.67176.75Price / Sales1.744,246.60373.54264,362.43Price / CashN/A13.1935.4527.97Price / Book0.2939.388.274.53Net Income-£5.45M-£90.99M£3.24B£5.90B7 Day Performance8.70%-1.82%-3.69%12.55%1 Month Performance2.88%11.25%4.33%6.07%1 Year Performance-68.27%189.83%25.95%71.57% Theracryf Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCFTheracryfN/AGBX 0.25+6.4%N/A-68.3%£1.19M£687.67K-0.2410Gap UpHigh Trading VolumeSTLStilo InternationalN/AN/AN/AN/A£3.42M£1.42M30.001,907Gap UpHWCHighway CapitalN/AN/AN/AN/A£1.78MN/A0.003,630Gap UpAGMApplied Graphene MaterialsN/AN/AN/AN/A£643K£127K-20.00160Gap DownFCRMFulcrum Utility ServicesN/AN/AN/AN/A£599K£50.55M-3.0050Gap DownSFESafestyle UKN/AN/AN/AN/A£444K£150.18M-4.5718,500ABTXABTX.LN/AN/AN/AN/A£0.00N/A0.00590High Trading VolumePGYProgilityN/AN/AN/AN/A£0.00N/A0.00800Gap DownHigh Trading VolumeSTELStellar DiamondsN/AN/AN/AN/A£0.00N/A0.001,020Gap UpTCATerra CapitalN/AN/AN/AN/A£0.00N/A0.002,200CHOCUnited Cacao Limited SEZCN/AN/AN/AN/A£0.00N/A0.00N/A Related Companies and Tools Related Companies STL Competitors HWC Competitors AGM Competitors FCRM Competitors SFE Competitors ABTX Competitors PGY Competitors STEL Competitors TCA Competitors CHOC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:TCF) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theracryf Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Theracryf With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
